First Annual UT Southwestern Multidisciplinary Endocrine Tumor Symposium: "Radioactive Iodine for Thyroid Cancer: Guidelines, Contraversies, and Practical Lessons" (RP2106C)
This live virtual CME activity is designed for physicians, nurses, and healthcare professionals in the specialties of endocrinology, medical oncology, radiation oncology, and medical oncology. Didactic presentations will provide a comprehensive review of current guidelines regarding the use of radioactive iodine (RAI) for thyroid cancer. Case presentations will provide practical lessons in applying the current guidelines.
This CME activity is intended for providers in the specialties of: Endocrinology, Oncology (Medical), Otolaryngology, Radiation Oncology, Radiology, and Surgery - Oncology.
Evaluate current and evolving guidelines for the use of RAI and determine how RAI could be applied (or should not be applied) in specific patient treatment modalities, in light of: 1!)2015 ATA guidelines on RAI in differentiated thyroid cancer (specifically using risk stratification and postoperative disease to guide RAI dosing); 2) Martinique principles for RAI treatment (remnant ablation, adjuvant therapy, treatment of known disease); 3) Thyrogen stimulation versus thyroid hormone withdrawal stimulation for RAI; 4) Optimal preparation with low iodine diet and counseling on radiation safety for outpatient treatment; 5) Utility of pre-treatment scanning with low dose I131 versus I123; and 6) Use of dosimetry to guide RAI dosing.
Identify and interpret current and evolving RAI guidelines and best practices, including: patient preparation, radiation safety, dosimetry, optimal scanning technique.
Expand application of RAI for individual patient management by healthcare team to ensure data driven, standard of care is being administered to promote best patient outcomes.
CLICK ON A PRESENTATION TITLE TO VIEW PRESENTATION SLIDES HANDOUT
12:45 PM Attendees log on to Zoom
12:55 PM Welcome & Introductions - Course Director: Shelby Holt, M.D.
1:oo PM “De-escalating Radioactive Iodine in Patients with Differentiated Thyroid Cancer: When to Use It And How Much?” – Michael Tuttle, M.D.
1:30 PM "Radioiodine Treatment for Thyroid Cancer: Why, When, and How" – Anca Avram, M.D.
2:00 PM Q & A Session With Our Guest Speakers – Moderator: David McFadden, M.D., Ph.D.
2:20 PM Break
2:30 PM Case Presentations – Moderator: David McFadden, M.D., Ph.D.
4:00 PM Closing Remarks and Adjourn
Shelby Holt, M.D.
Chief, Division of Endocrine Surgery
Professor, Department of Surgery
UT Southwestern Medical Center
David McFadden, M.D., Ph.D.
Assistant Professor of Internal Medicine and Biochemistry
UT Southwestern Medical Center
Anca Avram, M.D.
Clinical Professor, Radiology
Director, Nuclear Medicine Medical Student Education
University of Michigan
Ann Arbor, MI
Michael Tuttle, M.D.
Professor of Medicine
Clinical Director, Endocrine Service
Memorial Sloan Kettering Hospital
New York, NY
DISCLOSURE OF COMMERCIAL INTEREST
As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), The University of Texas Southwestern Medical Center, Office of Continuing Medical Education (UTSW CME) requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. Planning must be free of the influence or control of a commercial entity and promote improvements or quality in healthcare.
All persons in the position to control the content of an education activity are required to disclose all relevant financial relationships in any amount occurring within the past 12 months with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients.
The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. The UTSW Office of CME has implemented a mechanism to identify and resolve all conflicts of interest prior to the activity. The intent of this policy is to identify potential conflicts of interest so participants can form their own judgments with full disclosure of the facts.
Course Director/Speaker/Planner Names
Disclosure of Relevant Financial Relationships
Shelby Holt, M.D. (Course Director)
All reported having no relevant financial relationships
David McFadden, M.D., Ph.D. (Moderator, Planner)
Anca Avram, M.D. (Speaker)
Michael Tuttle, M.D. (Speaker)
Orhan Oz, M.D., Ph. D. (Planner)
Gabby Hernandez (Planner)
Mark Vinciguerra (CME Program Coordinator)
The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Texas Southwestern Medical Center designates this continuing education activity for a maximum of 2.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The University of Texas Southwestern Medical Center certifies that non-physicians will receive an attendance certificate stating that they participated in the activity that was designated for a maximum of 2.75 AMA PRA Category 1 Credits™.
- 2.75 AMA
- 2.75 Attendance
To register for this symposium, please email: Gabby.Hernandez@UTSouthwestern.edu
After attending the symposium:
All attendees will receive an email from the CME Office, with instructions and a link for: verifying attendance, accessing conference materials, completing the course evaluation, and claiming CME or Attendance credit..
REQUIREMENTS FOR COMPLETING THE COURSE:
- Attend the June 4, 2021 Live Virtual Session
- Complete the Course Evaluation
- Claim the number of credits/hours you participated and are claiming
Once all of these requirements are fulfilled, credits are posted to your Ethos account/activity transcript, and you may then view/download/print your CME/Attendance certificate.